Please login to the form below

Not currently logged in
Email:
Password:

ATMPs

This page shows the latest ATMPs news and features for those working in and with pharma, biotech and healthcare.

Europe urged to adapt faster to gene therapy challenges

Europe urged to adapt faster to gene therapy challenges

ATMP-dedicated funds, allowing health systems to invest in ATMPs that offer the potential for long-term benefits. ... Expansion of opportunities for early dialogue between ATMP developers and payers, supported by increased EU funding.

Latest news

More from news
Approximately 3 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    177 requests for eligibility, or 8 a month on average. 71 requests have been chemical products, 43 biological, 42 ATMPs with the last 13 classed as ‘other’.

  • Europe vs the US: New drug product approvals Europe vs the US: New drug product approvals

    Two Advanced Therapy Medicinal Products (ATMP), Strimvelis (for the treatment of severe combined immunodeficiency) and Zalmoxis (for the treatment of certain types of high-risk haematological malignancies), were approved in the

  • Gathering pace: adaptive pathways Gathering pace: adaptive pathways

    Applications included six advanced-therapy medicinal products (ATMPs) and 12 orphan drugs, while 14 of them were for new cancer therapies. ... The first of these in-depth discussions, on the quality aspects of an ATMP, took place in December 2014, with

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics